Blood Bank Polansky Review Flashcards
AABB criteria for whole blood donors
age allogenic
> 16 or allowed by state
Criteria for whole blood donors HGB/HCT allogenic
hgb >12.5g/dl
Hct >38%
Temperature of whole blood donation criteria allogenic
<99.5 f or 37.5c
Autologous whole blood donation requirements
age
hgb/hct
temperature
age determined by director
hgb >11g/dl
hct >33%
bacteremia is cause for deferral in temperature
aspirin deferral (if donor is sole source of platelets)
2 days
measels/rubeola, mumps, polio, yellow fever vaccine deferral
2 weeks
rubella, chicken pox (varicella zoster) vaccine deferral
4 weeks
pregnancy deferral
6 weeks
whole blood donation deferral
8 weeks
syphillis, gonorrhea, skin penetration, hepatitis contact, high risk HIV, Iraq travel…etc deferral
12 mos
malaria or endemic region deferral
3 years
permanent deferrals
parenteral drug use
CJD
GH treatment
hepatitis after 11yrs
Hep B
Chagas/bebesiosis
volume of blood collected routinely
450 - 500ml
Time of collection of whole blood
<10min, if >15-20min unit may not be suitable for prep of platelets or plasma
apheresis explanation
removal of 1 or more components of blood from donor and return of remainders to donor
advantages of apheresis
allows collection of larger volumes of specific components, reduces number of donors pt is exposed to
Donor testing required by AABB/FDA
Type ABO/Rh (weak D)
Ab Screen
Syphilis
Hep
HIV
HTLV
WNV
bacterial cultures
ACD-A anticoag
acid citrate dextrose
21 day life
chelates calcium, apheresis
CPD anticoag
citrate phosphate dextrose
21 days
higher pH , better 02 delivery
CP2D anticoag
citrate phos double dextrose
21 days
contains 100% more glucose than CPD
CPDA-1 anticoag
citrate phos dextrose w adenine
35 days
increases ATP, longer cell storage
additive solution purpose
consituents
lowers?
extends shelf life of rbcs to 42 days
glucose for energy, ATP
lowers viscosity
Examples of rbc additive solutions
AS-1, AS-3 AS-5
Open system
seal on unit is broken to attach external transfer bag, exposure to air poses bacterial contam
used w/in 24hr after opened, stored within 4 hr
closed system
sterilty maintained through satellite bags or device, welds tubing from one bag to another, no air exposure
no change in expiration
RBC storage temp
shelf life
indications
Hct
centrifuge to separate out WBC
store 1-6c
35 days in CPDA-1
inadequate tissue oxygenation
HCT >80%
how much does one unit of rbcs change HCT/HGB
1 unit increases Hgb 1g/dl
Hct 3%
Rbcs adenine, saline added storage
shelf
removal of most plasma
1-6c
42 days
mOST COMMONLY USED PRODUCT
frozen rbcs
storage
shelf
frozen in glycerol w/in 6 days
<65c after deglyc 1-6c
10yrs, after thaw 24hr
safe for IgA def patients, used to store rare cells
washed rbcs
storage
shelf
indications
washed with saline
1-6c
expires 24hr after wash
hxt of severe allergic rxn
not sub for wbc reduced rbcs
RBC leukoreduced
storage
shelf
indications
filtration/apheresis method
1-6c
history of febrile rxn
85% original rbcs must be retained
<5x10^6 wbc
irradiated rbcs
storage
shelf
indications
cGy irradiation
1-6c
origninal out date or 28 days from irradiation
immunodef,malignancy
prevention of GVH, kills donor t cells
FFP
storage
shelf
plasma sep from wb and frozen w/in 8 hr
frozen: <-18c
after thaw 1-6c
frozen: 12mos
thaw: 24hr
coag factor def, contains all coag factors
Cryoprecipitate
prep
storage
shelf
indications
thaw FFP at 1-6c, remove plasma, refreeze w/in 1hr
frozen: <-18c
after thaw: RT
frozen: 12mos
thaw: single unit 6hr, pool 6hr if sterile device (4hr regular)
factor I and vIII deficiencies
hemophilia A/VWD
Platelets
prep
strorage
shelf
centrifuge w/in 8hr
1st soft spin, (rich plasma) 2nd hard spin (separates plts)
20-24c
5 days from collection, after pooling 4hr
severe tp or abn plt function
Platelet component requirements
> 5.5 x 10^10 plts
ph >6.2
incs plts by 5000-10,000 in one unit
apheresis plt
storage temp
shelf life
plt count
20-24c
5 days with agitation
>3.0 x 10^11plts
Leukoreduced plt components
storage
shelf
indications
wbc removed,
20-24c
open system 4hr
apheresis 5 days
recurrent febrile rxn, decrease risk of CMV/HLA
prestorage pooled plts
prep
storage
shelf
ABO identical plts pooled in closed system
20-24c
5 days from collection
Leukoreduction purpose
wbc count
methods
to dec wbcs to dec febrile rxn, CMV, HLA
<5 x 10^6 wbcs
apheresis, filtration, filters
RBC storage lesion
INC: Lactic acid, Plasma K, Hgb, Aggregates
Decreased: ATP, 2,3BPG, pH, glucose, viable cells, labile coag factors
shift to the left of curve (inc oxy affinity, decreased oxy to tissues)
Primary response
stimulous
lag phase
ab
titer
1st exposure to ag
days to mos lag
IgM first, IgG after 2wk
titer is slow, peaks then declines
Secondary response (anamnestic)
stimulous
lag phase
ab
titer
subsequent ag exposure
lag phase hours
IgG first
titer rises faster and higher, stays elevated longer
Clin sign ab react at what temperature
37c
pH of most ab rxns
5.5-8.5
ionic strength
reducing ionic strength facilitates interaction of ab with ag (LISS)
optimum serum to cell ratio
80:1
what does reducing zeta potential do
allows rbcs to move closer together
Gel testing
more sensative than tube, rxn stable for 2-3days
AHG doesnt require washing or control cells
Type O frequencies
Whites
blacks
hispanic
asian
white 45%
black 49%
hispanic 57%
asian 40%